Alexion Pharmaceuticals has announced key additions to its executive leadership team effective June 5, 2017.

Reporting to Chief Executive Officer Ludwig Hantson will be: John Orloff, M.D., Executive Vice President, Head of Research & Development; Anne-Marie Law, Executive Vice President, Chief Human Resources Officer; and Indrani Lall Franchini, J.D., Executive Vice President, Chief Compliance Officer.

“These highly talented executives brings deep industry experience and a proven track record in their respective areas of expertise,” Hanston said.